This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Personal history of allergy to analgesic agent
Z21_PERSONAL_HISTORY_ALLERGY_ANALGESIC_AGENT
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
207 |
4. Check minimum number of eventsNone |
207 |
5. Include endpointsNone |
207 |
6. Filter based on genotype QC (FinnGen only) |
207 |
Control definitions (FinnGen only)
- Control exclude
- CD2_BENIGN_FEMALE_GEN_OTH
Extra metadata
- Level in the ICD hierarchy
- 4
- Special
- ASAINTOL
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- Z88
Similar endpoints
↥List of similar endpoints to
Personal history of allergy to analgesic agent
based on the number of shared cases.
Similar with more cases:
- Personal history of allergy to drugs, medicaments and biological substances
- Persons with potential health hazards related to family and personal history and certain conditions influencing health status
- Factors influencing health status and contact with health services
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 207 | 140 | 67 |
| Unadjusted period prevalence (%) | 0.04 | 0.05 | 0.03 |
| Median age at first event (years) | 52.32 | 50.91 | 55.25 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 181
- Matched controls
- 1808
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
Z88.6
ICD-10 Finland
Personal history of allergy to analgesic agent
+∞
261.9
181
*
J33.0
ICD-10 Finland
Polyp of nasal cavity
124.8
105.6
108
21
J32.4
ICD-10 Finland
Chronic pansinusitis
179.4
101.3
99
12
DNB20
NOMESCO Finland
Endoscopic ethmoidectomy
109.0
97.7
102
21
J33.8
ICD-10 Finland
Other polyp of sinus
127.1
85.1
87
13
UDH02
NOMESCO Finland
Rhinopharyngoscopy
44.7
82.8
105
54
J45.1
ICD-10 Finland
Nonallergic asthma
47.1
82.0
102
48
DMB20
NOMESCO Finland
Functional endoscopic opening of maxillary antrum
43.4
80.1
102
52
R03DC03
ATC
montelukast; oral
25.2
77.4
133
179
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
24.6
76.5
133
183
DHB20
NOMESCO Finland
Polypectomy of internal nose
140.5
74.0
75
9
J45.0
ICD-10 Finland
Predominantly allergic asthma
27.4
68.9
102
81
R01AD08
ATC
fluticasone; nasal
18.6
63.6
149
361
J45.9
ICD-10 Finland
Asthma, unspecified
16.2
58.9
116
179
DM1AD
NOMESCO Finland
CT of paranasal sinuses and face area
47.8
58.6
71
24
XQ800
NOMESCO Finland
Prick test
19.2
51.0
84
78
TDM10
NOMESCO Finland
Puncture of maxillary antrum
26.4
51.0
73
45
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
18.5
49.8
83
79
C01CA24
ATC
epinephrine; parenteral
19.7
47.4
76
64
DPA30
NOMESCO Finland
Sphenotomy
288.4
45.1
44
*
H02AB06
ATC
prednisolone; systemic
12.8
44.9
156
592
R01AD05
ATC
budesonide; nasal
17.5
44.6
75
70
R03BB04
ATC
tiotropium bromide; inhalant
21.4
41.4
63
44
R03AC02
ATC
salbutamol; inhalant
12.9
38.7
163
746
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
15.9
37.2
64
60
R03AK06
ATC
salmeterol and fluticasone; inhalant
10.0
35.6
82
138
ZXA10
NOMESCO Finland
Bilateral
9.1
35.5
89
173
R03BA02
ATC
budesonide; inhalant
8.6
33.6
88
180
H02AB04
ATC
methylprednisolone; systemic
9.7
33.6
78
131
DPA25
NOMESCO Finland
Trephine of frontal sinus through nose
200.3
32.9
33
*
R03BA05
ATC
fluticasone; inhalant
7.6
30.1
85
189
J33.9
ICD-10 Finland
Nasal polyp, unspecified
77.1
29.0
32
5
H02AB07
ATC
prednisone; oral
7.9
28.9
77
155
R03DA04
ATC
theophylline; systemic, rectal
28.6
26.0
35
15
J45
ICD-10 Finland
Asthma
9.2
25.6
58
88
R03AK07
ATC
formoterol and budesonide; inhalant
5.8
23.4
82
227
R03AK08
ATC
formoterol and beclometasone; inhalant
17.0
22.5
36
26
R01AD09
ATC
mometasone; nasal
5.1
22.2
136
671
M01AE01
ATC
ibuprofen; systemic, rectal
0.2
21.9
88
1496
ZXC95
NOMESCO Finland
Use of surgical navigator
34.9
21.3
27
9
R01AD12
ATC
fluticasone furoate; nasal
4.7
21.0
103
398
R03AC12
ATC
salmeterol; inhalant
20.5
20.9
31
18
R03AC13
ATC
formoterol; inhalant
12.6
19.8
36
35
J46
ICD-10 Finland
Status asthmaticus
18.7
19.6
30
19
DM1AI
NOMESCO Finland
Cone beam CT of paranasal sinus
17.9
18.7
29
19
WX408
NOMESCO Finland
General anesthesy, balanced
4.6
18.7
84
289
R06AX27
ATC
desloratadine; oral
4.3
18.6
96
373
J01AA02
ATC
doxycycline; systemic
7.9
18.3
169
1157
DHA10
NOMESCO Finland
Biopsy of cavity of nose
198.6
17.8
18
*
R06AE07
ATC
cetirizine; oral
4.0
17.6
120
592
R01AD58
ATC
fluticasone, combinations; inhalant, nasal
4.3
17.3
81
285
GX1L5
NOMESCO Finland
Exhaled nitric oxide analysis
99.4
16.9
18
*
WX002
NOMESCO Finland
Sedation and analgesia
4.8
16.5
64
185
J32.2
ICD-10 Finland
Chronic ethmoidal sinusitis
52.7
16.4
19
*
DHB50
NOMESCO Finland
Turbinoplasty
15.8
16.1
26
19
D72.1
ICD-10 Finland
Eosinophilia
+∞
15.9
15
*
R01AD01
ATC
beclometasone; nasal
4.9
15.8
58
158
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
10.5
15.7
31
35
R03AC03
ATC
terbutaline; inhalant
5.0
15.4
56
150
R06AE09
ATC
levocetirizine; oral
4.6
15.4
62
185
4222
FHL
Endonasal etmoidectomy
49.7
15.4
18
*
J33
ICD-10 Finland
Nasal polyp
87.4
14.8
16
*
R06AX13
ATC
loratadine; oral
4.5
14.3
58
173
R03BA01
ATC
beclometasone; inhalant
5.0
14.3
50
128
J45.8
ICD-10 Finland
Mixed asthma
14.4
13.9
23
18
XG474
NOMESCO Finland
Exhalation nntrogen oxide
15.5
13.7
22
16
J32.8
ICD-10 Finland
Other chronic sinusitis
150.8
13.6
14
*
4711A
ICD-9 Finland
Nasal polyps, Polypoid sinus degeneration
150.8
13.6
14
*
R03BA08
ATC
ciclesonide; inhalant
6.1
13.5
38
75
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
3.4
13.1
126
733
ZX112
NOMESCO Finland
Subcutaneous
26.6
12.7
17
7
J01.0
ICD-10 Finland
Acute maxillary sinusitis
3.5
12.0
69
269
Z51.6
ICD-10 Finland
Desensitization to allergens
18.0
11.9
18
11
R03DC01
ATC
zafirlukast; oral
27.0
11.3
15
6
J30.10
ICD-10 Finland
Allergic rhinitis due to pollen
6.7
11.0
28
48
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
7.0
10.6
26
42
J33.1
ICD-10 Finland
Polypoid sinus degeneration
+∞
10.5
10
*
T78.4
ICD-10 Finland
Allergy, unspecified
6.9
10.5
26
43
J01FA09
ATC
clarithromycin; systemic
2.9
10.2
86
431
J01FA10
ATC
azithromycin; systemic
3.0
10.1
136
908
WX402
NOMESCO Finland
General anaesthesia
3.5
10.0
53
193
DMB00
NOMESCO Finland
Endonasal trephine of maxillary antrum
27.8
10.0
13
5
R03AK11
ATC
formoterol and fluticasone; inhalant
12.4
9.8
17
15
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
3.9
9.6
42
130
R03BB01
ATC
ipratropium bromide; inhalant
18.8
9.6
14
8
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
13.4
9.6
16
13
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.7
9.4
87
456
J01FA06
ATC
roxithromycin; oral
2.7
9.1
94
523
R06AX22
ATC
ebastine; oral
3.1
9.1
56
226
R01BA52
ATC
pseudoephedrine, combinations; oral
2.8
9.0
78
389
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
7.6
8.8
20
29
4730A
ICD-9 Finland
Chronic sinusitis, Maxillary
17.4
8.7
13
8
N02AX02
ATC
tramadol; systemic, rectal
2.6
8.6
88
481
R03AK10
ATC
vilanterol and fluticasone furoate; inhalant
8.6
8.6
18
23
R96
ICPC
Asthma
4.7
8.6
29
70
XQ820
NOMESCO Finland
Exposure to medicinal substance
29.1
8.6
11
*
H65.3
ICD-10 Finland
Chronic mucoid otitis media
10.8
8.2
15
15
Z01.7
ICD-10 Finland
Laboratory examination
3.9
8.0
34
102
DJD20
NOMESCO Finland
Plastic repair of septum of nose
7.3
7.8
18
27
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
2.4
7.7
98
592
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
3.8
7.6
33
101
N02AJ06
ATC
codeine and paracetamol; systemic
2.4
7.5
87
498
3028
Kela drug reimbursment
Mepolizumab
+∞
7.3
7
*
R03DX09
ATC
mepolizumab; parenteral
+∞
7.3
7
*
297
Kela drug reimbursment
NA
+∞
7.3
7
*
J32.9
ICD-10 Finland
Chronic sinusitis, unspecified
16.6
7.3
11
7
J01DA06
ATC
[U] cefuroxime; systemic
3.1
7.3
42
160
N02BE01
ATC
paracetamol; systemic, rectal
3.2
7.3
160
1277
J34.2
ICD-10 Finland
Deviated nasal septum
5.1
7.2
22
48
R4110
NOMESCO Finland
Physiotherapy
2.6
7.1
63
311
A02BC05
ATC
esomeprazole; systemic
2.3
6.8
83
481
DFF00
NOMESCO Finland
Pure tone audiometry
4.8
6.8
22
51
J01CA04
ATC
amoxicillin; systemic
3.2
6.8
162
1319
DCA10
NOMESCO Finland
Paracentesis of tympanic membrane
12.9
6.7
11
9
T88.6
ICD-10 Finland
Anaphylactic shock due to adverse effect of correct drug or medicament properly administered
72.3
6.5
7
*
DPA20
NOMESCO Finland
Trephine of frontal sinus
72.3
6.5
7
*
UDM02
NOMESCO Finland
Sinoscopy
7.5
6.4
14
20
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
5.8
6.3
17
32
H72.0
ICD-10 Finland
Central perforation of tympanic membrane
18.8
6.3
9
5
4239
FHL
Other measure in this category
+∞
6.3
6
*
4224
FHL
Endonasal anthrostomy
13.1
6.2
10
8
J30.3
ICD-10 Finland
Other allergic rhinitis
5.9
6.2
16
29
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.6
6.1
49
227
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
70
37
28.07
93.47
1.5
1.2
0.5
0.8
u/ml
0.45
61
16
35
12
34.90
53.45
1.3
1.1
1.3
0.1
u/ml
—
18
6
190
1008
11.78
31.23
6.8
9.6
4.0
4.0
e9/l
0.12
159
888
18
33
5.88
9.63
2.5
5.5
58.6
57.9
%
0.08
18
33
18
33
5.88
9.63
2.5
4.5
4.8
4.8
e9/l
0.01
18
33
200
1691
6.40
9.40
15.8
12.0
41.6
40.5
%
3.35
176
1368
13
9
15.30
8.32
1.3
3.4
40.3
18.0
ug/l
—
13
9
10
13
8.03
7.18
5.4
2.8
—
—
—
0
0
14
30
4.93
6.31
1.4
1.4
—
—
—
0
0
192
1637
3.39
5.43
11.5
9.9
91.1
89.1
ml/min/173m2
0.85
168
1325
70
415
2.04
5.22
3.1
2.6
0.2
0.4
e6/l
0.80
43
309
35
158
2.46
5.04
2.0
2.3
25.3
28.6
u/l
0.95
26
131
29
128
2.47
4.37
3.8
3.1
—
—
—
0
0
71
446
1.90
4.36
1.7
1.6
—
—
—
0
0
20
75
2.84
4.13
6.2
4.6
25.8
25.0
mmol/l
0.43
20
75
18
67
2.85
3.77
2.5
1.6
—
—
—
0
0
19
75
2.69
3.58
2.1
1.5
—
—
—
0
0
5
189
0.25
3.46
3.4
4.2
38.4
31.7
%
—
5
121
10
27
3.84
3.39
1.5
1.2
—
—
—
0
0
10
27
3.84
3.39
1.5
1.2
—
—
—
0
0
58
367
1.81
3.38
1.7
1.7
2.1
0.9
mg/l
0.37
44
285
41
235
1.93
3.24
2.0
2.5
1.4
2.8
e6/l
0.86
13
116
207
1988
+∞
3.22
19.9
17.1
137.7
136.6
g/l
0.60
207
1965
194
1761
2.62
3.01
13.2
11.0
23.1
21.1
mg/l
0.33
166
1325
61
407
1.71
2.92
2.0
2.5
310.0
5169.3
umol/l
1.46
51
361
42
257
1.80
2.70
2.0
2.4
0.5
0.8
e6/l
0.34
13
135
22
107
2.18
2.69
1.0
1.0
—
—
—
0
0
13
50
2.71
2.58
1.0
1.2
—
—
—
0
0
13
50
2.71
2.58
1.0
1.2
—
—
—
0
0
73
525
1.60
2.57
3.2
2.8
—
—
—
0
0
63
437
1.63
2.57
1.3
1.3
0.7
1.3
u/ml
1.09
12
132
6
12
5.11
2.42
1.0
2.1
—
—
—
0
0
8
22
3.74
2.39
1.1
1.3
—
—
—
0
0
27
149
1.93
2.38
1.5
1.7
—
—
—
0
0
9
29
3.20
2.25
1.0
1.2
—
—
—
0
0
27
154
1.87
2.17
1.5
1.7
—
—
—
0
0
9
31
2.99
2.10
1.6
1.1
—
—
—
0
0
157
1377
1.58
2.09
4.1
3.6
—
—
—
0
0
39
253
1.67
2.04
2.7
2.4
2.4
2.4
mmol/l
0.26
32
224
13
57
2.37
2.02
1.2
1.2
—
—
—
0
0
181
1652
1.76
1.97
3.4
3.9
5.6
5.8
mmol/l
0.75
166
1538
14
65
2.24
1.93
1.3
1.6
—
—
—
0
0
148
1292
1.51
1.92
2.4
3.0
30.2
41.7
u/l
4.27
141
1226
16
80
2.08
1.85
1.7
1.5
—
—
—
0
0
38
254
1.61
1.77
2.9
3.3
18.0
274.1
ng/l
1.11
23
170
103
848
1.43
1.75
3.6
5.9
9.5
10.3
umol/l
0.80
95
806
31
202
1.63
1.60
1.6
2.5
4.1
6.6
umol/l
1.21
24
167
20
115
1.82
1.59
1.4
1.3
18.3
24.2
iu/l
0.52
15
101
33
223
1.57
1.48
1.8
1.8
—
—
—
0
0
150
1346
1.42
1.42
3.7
4.1
14.2
14.5
pmol/l
1.07
139
1242
99
832
1.36
1.40
3.8
4.4
0.0
0.0
estimate
0.00
21
161
15
82
1.89
1.39
1.5
1.5
—
—
—
0
0
15
82
1.89
1.39
1.5
1.5
—
—
—
0
0
15
82
1.89
1.39
1.5
1.5
—
—
—
0
0
15
82
1.89
1.39
1.5
1.5
—
—
—
0
0
5
17
2.99
1.36
1.0
1.2
—
—
—
0
0
84
693
1.36
1.32
2.1
2.3
73.2
75.7
nmol/l
0.34
73
627
66
525
1.38
1.30
2.9
3.3
2.3
2.4
mmol/l
0.55
57
461
10
48
2.14
1.30
1.6
1.6
—
—
—
0
0
98
830
1.34
1.29
2.7
3.2
0.0
0.0
estimate
0.00
22
155
76
622
1.35
1.25
2.7
4.5
37.3
36.9
g/l
0.31
67
588
99
844
1.33
1.23
2.7
3.2
0.0
0.0
estimate
0.00
20
157
28
191
1.54
1.22
2.1
1.9
—
—
—
0
0
82
684
1.33
1.17
3.8
6.2
1.2
1.2
mmol/l
0.36
64
596
23
152
1.58
1.15
1.6
1.8
—
—
—
0
0
10
51
2.01
1.13
1.3
1.9
—
—
—
0
0
11
192
0.55
1.12
6.2
6.0
—
—
—
0
0
69
569
1.32
1.05
1.9
1.8
94.1
95.5
pmol/l
0.08
34
285
56
450
1.34
1.02
1.5
1.6
1.4
1.4
mmol/l
0.14
47
389
47
369
1.35
0.99
1.7
1.4
—
—
—
0
0
10
54
1.90
0.98
1.4
1.4
—
—
—
0
0
0
30
0.00
0.98
0.0
1.8
—
7.1
—
0
18
15
93
1.66
0.97
1.7
1.5
—
—
—
0
0
139
1268
1.29
0.95
5.7
7.2
69.8
74.2
u/l
1.09
131
1178
30
220
1.43
0.94
2.1
3.1
0.8
0.8
mmol/l
0.99
30
209
170
1604
1.33
0.83
4.7
4.7
1.7
1.8
mu/l
1.28
162
1492
16
110
1.49
0.71
1.1
1.4
—
—
—
0
0
92
831
1.19
0.59
3.1
2.8
100.4
88.5
ug/l
0.13
84
777
28
222
1.30
0.58
1.8
1.5
1157.2
1213.7
nmol/l
0.09
16
169
181
1746
1.29
0.55
3.8
4.3
2.9
2.9
mmol/l
0.04
169
1636
11
74
1.51
0.54
1.5
1.4
—
—
—
0
0
72
650
1.17
0.45
2.6
3.2
—
—
—
0
0
5
31
1.63
0.43
2.8
3.4
12.2
16.1
u/ml
—
5
31
21
259
0.79
0.42
1.6
1.6
428.7
464.2
pmol/l
0.39
12
231
5
33
1.53
0.41
1.0
1.1
—
—
—
0
0
5
33
1.53
0.41
1.2
1.2
—
—
—
0
0
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
0
15
0.00
0.41
0.0
2.1
—
—
—
0
0
0
15
0.00
0.41
0.0
1.5
—
—
—
0
0
0
16
0.00
0.41
0.0
1.9
—
—
—
0
0
0
16
0.00
0.41
0.0
1.9
—
—
—
0
0
0
16
0.00
0.41
0.0
1.9
—
—
—
0
0
31
363
0.83
0.39
4.5
4.3
1.5
1.7
ug/l
0.34
26
320
0
19
0.00
0.39
0.0
3.4
—
70.5
—
0
19
26
217
1.23
0.38
3.1
2.6
0.4
0.8
ug/l
2.61
14
129
5
78
0.63
0.36
1.2
1.6
—
—
—
0
0
171
1660
1.17
0.34
3.0
3.6
1.2
1.3
mmol/l
1.21
159
1557
12
92
1.32
0.32
1.3
1.5
—
—
—
0
0
36
316
1.17
0.32
1.4
1.3
11.0
24.8
iu/ml
—
9
109
76
815
0.89
0.30
3.0
3.8
—
—
—
0
0
7
56
1.26
0.29
1.3
1.1
—
—
—
0
0
5
72
0.69
0.26
1.4
1.7
—
—
—
0
0
176
1726
1.13
0.21
3.4
4.0
4.9
4.8
mmol/l
0.39
166
1630
0
11
0.00
0.21
0.0
8.6
—
34.0
—
0
5
0
10
0.00
0.21
0.0
1.9
—
—
—
0
0
0
10
0.00
0.21
0.0
3.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.9
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
1.9
—
—
—
0
0
0
10
0.00
0.21
0.0
1.9
—
—
—
0
0
0
10
0.00
0.21
0.0
1.6
—
—
—
0
0
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
0
12
0.00
0.21
0.0
1.9
—
16.1
—
0
12
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
0
12
0.00
0.21
0.0
1.1
—
1.2
—
0
7
0
13
0.00
0.21
0.0
1.4
—
—
—
0
0
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
175
1717
1.12
0.20
3.4
3.9
1.6
1.5
mmol/l
2.23
164
1615
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
16
137
1.18
0.19
5.4
6.9
1.5
1.3
mmol/l
0.09
11
108
57
540
1.08
0.15
2.8
3.0
15.1
43.4
ng/l
1.77
28
304
18
162
1.12
0.12
1.6
1.5
—
—
—
0
0
21
229
0.91
0.11
1.7
1.6
—
—
—
0
0
5
46
1.09
0.09
3.8
3.6
12.4
233.2
u/ml
—
5
39
52
500
1.05
0.08
1.9
2.4
50.2
56.0
u/l
1.67
45
465
10
113
0.88
0.08
7.4
7.4
123.1
124.0
g/l
—
10
108
41
392
1.06
0.08
1.7
2.0
—
—
—
0
0
6
70
0.85
0.08
1.5
2.5
0.9
1.5
%
—
6
70
12
132
0.90
0.07
2.3
2.1
82.2
73.4
ml/min/173m2
—
5
59
90
917
0.97
0.06
3.8
3.9
6.3
6.5
mmol/l
0.55
85
838
17
159
1.08
0.05
4.7
5.6
105.2
104.1
mmol/l
0.37
17
154
32
312
1.03
0.02
1.3
1.3
5.4
7.0
u/ml
0.16
14
131
18
184
0.98
0.00
2.7
5.3
1.1
1.0
mmol/l
0.91
18
169
28
284
0.98
0.00
3.5
4.1
17.3
21.2
%
—
6
121
37
366
1.01
0.00
2.1
2.1
—
—
—
0
0
33
333
0.99
0.00
2.0
1.9
—
—
—
0
0
43
435
0.99
0.00
3.3
3.4
0.0
0.0
estimate
0.50
22
161
154
1535
1.01
0.00
4.3
4.8
38.0
38.5
mmol/mol
0.31
144
1453
7
73
0.96
0.00
1.1
1.9
—
—
—
0
0
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
0
6
0.00
0.00
0.0
2.3
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
1644.8
—
0
8
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
0.00
0.0
3.6
—
57.3
—
0
5
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
0
5
0.00
0.00
0.0
2.6
—
—
—
0
0
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
0
6
0.00
0.00
0.0
2.3
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
0
6
0.00
0.00
0.0
2.3
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
0
7
0.00
0.00
0.0
2.1
—
—
—
0
0
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
6
60
1.00
0.00
1.3
2.2
—
—
—
0
0
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
0.00
0.0
2.6
—
—
—
0
0
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: Z21_PERSONAL_HISTORY_ALLERGY_ANALGESIC_AGENT – Personal history of allergy to analgesic agent
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).